The Supreme Court had asked the DTAB to decide on the fate of 349 FDCs banned by the government between March 2016 and June 2017 under Section 26A of the Drugs and Cosmetics Act and submit a report with its recommendations to the government within six months. DTAB will also deliberate a p...
In 2018, SAMR imposed a fine of RMB 8.49 million (approx.. USD1.22 million or EUR1.1 million) on a local pharma company (Erkang Pharma) for abuse of dominance on the market of chlorphenamine maleate. This fine was calculated on ...
·casipharma.com.cn CASI宣布CID-103治疗ITP的I/II期临床试验完成首例患者给药 2025年1月6日,CASI正式宣布,在中国和美国同步开展的CID-103用于成人持续性/慢性免疫性血小板减少症(ITP)的I/II期临床试验已在国内完成首例患者给药。本次试验旨在评估CID-103的安全性和耐受性。 CASI董事长兼首席执行官何为无博士...